GELMEDIX
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reduce the usage of drops which cause inconvenience to patients.
GELMEDIX
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.gelmedix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google Google Cloud Sectigo SSL Sectigo Domain SSL
Current Employees Featured
Founder
Investors List
Safar Partners
Safar Partners investment in Seed Round - Gelmedix
HTL Innovations
HTL Innovations investment in Seed Round - Gelmedix
EQx Fund
EQx Fund investment in Convertible Note - Gelmedix
Safar Partners
Safar Partners investment in Convertible Note - Gelmedix
Official Site Inspections
http://www.gelmedix.com Semrush global rank: 5.99 M Semrush visits lastest month: 1.37 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Gelmedix"
Home | GelMEDIX, Inc.
GelMEDIX was founded after multiple years of fruitful academic collaboration between our co-founders Reza Dana (Mass. Eye And Ear, Harvard Med. School) and Nasim Annabi (UCLA). Contact. 238 Main St, Fifth Floor, Cambridge, MA …See details»
Gelmedix - Crunchbase Company Profile & Funding
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can …See details»
Team | GelMEDIX, Inc.
Max works at the intersection of science and business operations for GelMEDIX, and has been with the team since company founding. Prior to GelMEDIX, he completed his PhD in Medical Engineering from MIT in the Harvard-MIT …See details»
GelMEDIX - LinkedIn
GelMEDIX Inc. is an early-stage biotechnology company leveraging its hydrogel platform to develop ocular and regenerative therapies that can restore vision.See details»
GelMEDIX Company Profile 2024: Valuation, Funding
GelMEDIX General Information Description. Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. The company's platform focuses on bio-adhesion, tissue …See details»
GelMEDIX, Inc. Company Profile | Newton, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GelMEDIX, Inc. of Newton, MA. Get the latest business insights from Dun & Bradstreet.See details»
GelMedix - VentureRadar
GelMEDIX can replace today’s drug regimens that require application of eye drops 4-12x per day over several weeks with a single, non-invasive gel patch. GelMEDIX’s gel could also be used …See details»
GelMEDIX - Products, Competitors, Financials, Employees, …
GelMEDIX operates an early-stage biotechnology company focused on developing ocular cell therapies and regenerative treatments to restore vision. Its offerings include engineering …See details»
Our Technology - GelMEDIX, Inc.
GelMEDIX's proprietary injectable, in situ forming hydrogel technology overcomes the fundamental challenges of cell replacement therapies and has been shown in vivo to improve cell localization and phenotype post-injection. Our lead …See details»
Gelmedix - Crunchbase
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment.See details»
Gelmedix - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Gelmedix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 3. ... Gelmedix …See details»
HTL announces its incubator's equity investment in GelMEDIX, an …
About GelMEDIX GelMEDIX Inc. is an early-stage biotechnology company committed to innovating the next generation of ocular and regenerative therapies through its proprietary …See details»
HTL Announces Its Incubator's Equity Investment In GelMEDIX, An …
Mar 10, 2022 GelMEDIX is developing drug products for indications across the eye focused on cell-based therapies for vision restoration, intraocular sustained release of small molecules …See details»
GelMEDIX investment - HTL Biotechnology
Mar 10, 2022 GelMEDIX HTL announces its incubator’s equity investment in GelMEDIX, an early-stage biotech aiming at revolutionizing ocular and regenerative therapies. This …See details»
Gelmedix - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... obfuscated. obfuscated — Mar 10, 2022: Seed Round - …See details»
Research programme: ocular and regenerative therapeutics
Ocular and regenerative therapeutics are being developed by GelMEDIX using its proprietary hydrogel platform for the treatment of eye disorders. The Research programme: ocular and …See details»
HTL Announces Its Incubator's Equity Investment In GelMEDIX, An …
Mar 10, 2022 HTL's incubator will support GelMEDIX through a direct investment and industrial and scientific support throughout its development thanks to its expertise in biopolymers and …See details»
Gelmetix – Transforming Individuals' Lives
Restore the equilibrium We focus on the treatment of chronic low back pain caused by the degeneration of intervertebral discs. Our patented polymer gel helps to restore the natural …See details»
Gelmetix - Crunchbase Company Profile & Funding
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like Chronic Lower Back pain and Osteoarthritis.See details»
News - GelMEDIX, Inc.
Jun 29, 2021 GelMEDIX is excited to present never-before-seen data on novel approaches to RPE regeneration at the upcoming ARVO and OIS Retina conferences in Seattle. We'll share …See details»